Feb 27, 2024
In Parliament his month questions were posed to Andrew Stephenson, Secretary of State for Health and Social Care by Peter Grant MP (SNP). He asked ‘What steps the Department is taking to ensure that there is an adequate supply of Oxcarbazepine for patients with...
Feb 8, 2024
WaveData conducted a comparison of the average market prices given to accounts (pharmacies and dispensing doctors) by respiratory product manufacturers. The average discounts given over a 10 year period are very consistent at 9%, which probably reflects the underlying...
Nov 9, 2023
It would seem sensible to assume that profitable products are less likely to suffer shortages, concessions and price spikes than products where profit is hard to come by. Charles Joynson, WaveData MD, compared the reimbursement price and the average market price for...
Oct 10, 2023
Charles Joynson, WaveData MD, drilled into this to see where the increase is coming from, demonstrating that it’s a mixture of parallel import and generics which are driving the rise. – Parallel imports have risen from £22.73 in Sept 2013 to 26.24 in August...
Aug 24, 2023
Normally we expect branded devices to maintain their pharmacy purchase prices over long periods of time. However, here this is not the case. Charles Joynson, WaveData MD investigates further. Looking at the long term market price trends of Freestyle Optium Test Strips...
May 31, 2023
Since Jan 2021 Naftidrofuryl Caps 100mg 84 has been granted concessions in 25 out of 29 months. This category M vasodilator is used by people with peripheral vascular disease, and can be severe enough to require the amputation of toes or feet. Over the last 20 years...
